Total Funding
46
7
Total FundingFunding Round raised
Growth Score 46 in past quarter
-17 pts
Heat Score 7 in past quarter
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
See more interactive data and historical milestones on desktop for the best experience
224942
BioIVT is a worldwide provider of biological and in vitro products to pharmaceutical and biotechnology organizations
Shannon Richey: Vice President & General Manager, Asterand Bioscience Detroit OperationsPast Role: Assay Designs, Director of Sales & Marketing- Pamela Filipowicz: Director of Human ResourcesPast Role: PPOM, Team Member
About the Company
Headquartered in Westbury, NY, BioIVT is the leading provider of biological and in vitro products to the biopharmaceutical, diagnostic, and biotechnology organizations. BioIVT’s products are used in drug discovery, biomarker, toxicology, bioanalytical, and ADME research. The company’s products and value added services enable its clients to
significantly reduce the time and expense of bringing new drugs and diagnostics to market.
